After de novo assembly using Trinity, how to calculate coverage??
-
Last edited by ankitarathore; 05-21-2013, 12:31 AM. -
Hi, I want to run a de novo with trinity. Which command should I use to start? I have single reads in fq
thanks -
You should check http://trinityrnaseq.sourceforge.net/ for details.
But something like the following should get you running:
Trinity --seqType fq --JM 100G --single reads.fq --CPU 6
Check your available RAM memory and number of cores to assign correctly the JM and CPU parameters. Substitute "reads.fq" for your read file.Comment
-
If RAM is 1GB then what to do?Comment
-
Not much (at least not in terms of de novo assembly). Unless the genome you are working on is the size of a small bacteriopahge.Originally posted by Nanu View PostComment
-
Genomax,
I executed the fastqc , fastx and indexing the reference genome through Bowtie. When i executing the tophat2..it created the accepted.bam and unmapped.bam, align-summary.txt, logs etc...
Here I got only 1 KB size of accepted hits..while unmapped.bam is 200MB in size. i have heterologous reference genome. I downloaded the genome from Ensembl database. I have to find the novel gene, its expression.
Is any particular pipeline for roche transcriptome data?
I am trying to evaluate as denovo through trinity for roche transcriptome data analysis. here increased the RAM as 6GB.
Please help me..Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment